생체재료학회지 (Biomaterials Research)

  • 제19권4호
  • /
  • Pages.218-227
  • /
  • 2015
  • /
  • 1226-4601(pISSN)
  • /
  • 2055-7124(eISSN)
한국생체재료학회 (Korean Society for Biomaterials)
권호 표지
DOI QR코드

DOI QR Code

Haemostatic chitosan coated gauze: in vitro interaction with human blood and in-vivo effectiveness

  • Pogorielov, M. (Sumy State University) ;
  • Kalinkevich, O. (Institute of Applied Physics) ;
  • Deineka, V. (Sumy State University) ;
  • Garbuzova, V. (Sumy State University) ;
  • Solodovnik, A. (Sumy State University) ;
  • Kalinkevich, A. (Institute of Applied Physics) ;
  • Kalinichenko, T. (Institute of Applied Physics) ;
  • Gapchenko, A. (Sumy State University) ;
  • Sklyar, A. (Sumy State Pedagogical University) ;
  • Danilchenko, S. (Institute of Applied Physics)
  • 투고 : 2015.09.18
  • 심사 : 2015.10.26
  • 발행 : 2015.12.31
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Chitosan and its derivates are widely used for biomedical application due to antioxidative, anti-inflammatory, antimicrobial and tissue repair induced properties. Chitosan-based materials also used as a haemostatic agent but influence of different molecular weight and concentration of chitosan on biological response of blood cells is still not clear. The aim of this research was to evaluate interaction between human blood cells and various forms of chitosan-based materials with different molecular weight and chitosan concentration and prove their effectiveness on in-vivo model. Methods: We used chitosan with molecular weight 200, 500 and 700 kDa and deacetylation rate 80-82 %. For chitosan impregnation of gauze chitosan solutions in 1 % acetic acid with different concentrations (1, 2, 3, 5 %) were used. We used scanning electron microscopy to obtain information about chitosan distribution on cotton surface; Erythrocyte agglutination test and Complete blood count test - for evaluation of interaction between blood cells and chitosan-based materials with different compound. In-vivo studies was performed in 20 Wistar rats to evaluate effectiveness of new dressing. Results: Our data shown that chitosan can bind erythrocytes in concentration-depend manner that does not depend on its molecular weight. In addition, chitosan-based materials affect selectively human blood cells. Composition of chitosan with cotton materials does not change erythrocyte shape and does not cause agglutination. Conclusions: Cotton-chitosan materials have higher adhesive properties to platelets that depend on molecular weight and concentration of chitosan. These materials also change platelets' shape that probable is one of the most important mechanisms of haemostatic effect. In-vivo studies have shown high effectiveness of 2 % 200 kDa chitosan for stop bleeding from arteries of large diameter.

키워드

참고문헌

  1. Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A Comprehensive Review of Topical Hemostatic Agents Efficacy and Recommendations for Use. Ann Surg. 2010;251:217-28. https://doi.org/10.1097/SLA.0b013e3181c3bcca
  2. Bettini R, Romani AA, Morganti MM, Borghetti AF. Physicochemical and cell adhesion properties of chitosan films prepared from sugar and phosphatecontaining solutions. Eur J Pharm Biopharm. 2008;68:74-81. https://doi.org/10.1016/j.ejpb.2007.03.026
  3. Brian TG. Effects of Celox and TraumaDEX on Hemorrhage Control in a Porcine Model. AANA Journal. 2010;78(2):115-20.
  4. Brown MA, Daya MR, Worley JA. Experience with Chitosan Dressings in a Civilian EMS System. J Emerg Med. 2009;37(1):1-7. https://doi.org/10.1016/j.jemermed.2007.05.043
  5. Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem and Biophy Res Com. 2003;302:480-3. https://doi.org/10.1016/S0006-291X(03)00173-6
  6. Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther. 2007;24:485-92. https://doi.org/10.1007/BF02848770
  7. Hirshberg A, Wall MJ, Ramchandani MK, Mattox KL. Reoperationfor bleeding in trauma. Arch Surg. 1993;128:1163-7. https://doi.org/10.1001/archsurg.1993.01420220083012
  8. Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 2010;62:3-11. https://doi.org/10.1016/j.addr.2009.09.004
  9. Kind GM, Bines SD, Staren ED, Templeton AJ, Economou SG. Chitosan: evaluation of a new hemostatic agent. Curr Surg. 1990;47:37-9.
  10. Klokkevold PR, Fukayama H, Sung EC, Bertolami CN. The effect of chitosan on lingual hemostasis in heparinized rabbits. J Oral Maxillofac Surg. 1999;57:49-52. https://doi.org/10.1016/S0278-2391(99)90632-8
  11. Koksal O, Fatma O, Betül CE, Naciye IB, Deniz S. Hemostatic effect of a chitosan linear polymer ($Celox^{(R)}$) in a severe femoral artery bleeding rat model under hypothermia or warfarin therapy. Turkish Journal of Trauma & Emergency Surgery. 2011;17(3):199-204. https://doi.org/10.5505/tjtes.2011.88155
  12. Kozen BG. An Alternative Hemostatic Dressing: Comparison of CELOX, HemCon, and QuikClot: Domard A. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials. 2000;22:261-8.
  13. Larson MJ, Bowersox JC, Lim Jr RC, Hess JR. Efficacy of a fibrin hemostatic bandage in controlling hemorrhage from experimental arterial injuries. Arch Surg. 1995;130:420-2. https://doi.org/10.1001/archsurg.1995.01430040082018
  14. Liu X, Ma L, Mao Z, Gao C. Chitosan-based biomaterials for tissue repair and regeneration. Chitosan for biomaterials II. In: Jayakumar R, Prabaharan M, Muzzarelli RAA, editors. Advances in polymer science. Heidelberg: Springer Berlin; 2011. p. 81-127.
  15. Madihally SV, Matthew HWT. Porous chitosan scaffolds for tissue engineering. Biomaterials. 1999;20:1133-42. https://doi.org/10.1016/S0142-9612(99)00011-3
  16. Mercy HP, Halim AS, Hussein AR. Hitosan-derivatives as hemostatic agents: their role in tissue regeneration. Regen Res. 2012;1:38-46.
  17. Neuffer MC, McDivitt J, Rose D, King K, Cloonan CC, Vayer JS. Hemostatic dressings for the first responder: a review. Mil Med. 2004;169:716-20. https://doi.org/10.7205/MILMED.169.9.716
  18. Ong S-Y, Wu J, Moochhala SM, Tan M-H, Lu J. Development of a chitosanbased wound dressing with improved hemostatic and antimicrobial properties. Biomaterials. 2008;29:4323-32. https://doi.org/10.1016/j.biomaterials.2008.07.034
  19. Park BK, Kim MM. Applications of chitin and its derivatives in biological medicine. Int J Mol Sci. 2010;11:5152-64. https://doi.org/10.3390/ijms11125152
  20. Pusateri AE, Holcomb JB, Harris RA, MacPhee MJ, Charles NC, Beall LD, et al. Effect of fibrin bandage fibrinogen concentration on blood loss after grade V liver injury in swine. Mil Med. 2001;166:217-22. https://doi.org/10.1093/milmed/166.3.217
  21. Pusateri AE, Kheirabadi BS, Delgado AV, Doyle JW, Kanellos J, Uscilowicz JM, et al. Structural design of the dry fibrin sealant dressing and its impact on the hemostatic efficacy of the product. J Biomed Mater Res B Appl Biomater. 2004;70:114-21.
  22. Pusateri AE, Modrow HE, Harris RA, Holcomb JB, Hess JR, Mosebar RH, et al. Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in swine. J Trauma. 2003;55:518-26. https://doi.org/10.1097/01.TA.0000075336.92129.27
  23. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential: J. Biomed Mater Res. 1997;34:21-8. https://doi.org/10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
  24. Rhee P, Brown C, Martin M, Salim A, Plurad D, Green D, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma. 2008;64:1093-9. https://doi.org/10.1097/TA.0b013e31812f6dbc
  25. Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31:603-32. https://doi.org/10.1016/j.progpolymsci.2006.06.001
  26. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of traumadeaths: a reassessment. J Trauma. 1995;38:185-93. https://doi.org/10.1097/00005373-199502000-00006
  27. Shen EC, Chou TC, Gau CH, Tu HP, Chen YT, Fu E. Releasing growth factors from activated human platelets after chitosan stimulation: a possible biomaterial for platelet-rich plasma preparation. Clin Oral Impl Res. 2006;17:572-8. https://doi.org/10.1111/j.1600-0501.2004.01241.x
  28. Shi C, Zhu Y, Ran X, Wang M, Su Y, Cheng T. Therapeutic Potential of Chitosan and Its Derivatives in Regenerative Medicine. J Surg Res. 2006;133:185-92. https://doi.org/10.1016/j.jss.2005.12.013
  29. Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosanbased hemostatic dressing: experience in current combat operations. J Trauma. 2006;60:655-8. https://doi.org/10.1097/01.ta.0000199392.91772.44

피인용 문헌

  1. Recent Trends in Alginate, Chitosan and Alginate-Chitosan Antimicrobial Systems vol.11, pp.2, 2015, https://doi.org/10.19261/cjm.2016.11(2).03
  2. Novel Cellulose-Halloysite Hemostatic Nanocomposite Fibers with a Dramatic Reduction in Human Plasma Coagulation Time vol.11, pp.17, 2015, https://doi.org/10.1021/acsami.9b04615
  3. Chitosan-Based Bioactive Hemostatic Agents with Antibacterial Properties-Synthesis and Characterization vol.24, pp.14, 2015, https://doi.org/10.3390/molecules24142629
  4. THE MECHANISM OF CLOTS FORMATION IN BLOOD PLASMA UNDER THE ACTION OF CHITIN DERIVATIVES vol.12, pp.4, 2015, https://doi.org/10.15407/biotech12.04.057
  5. Naturally Prefabricated Marine Biomaterials: Isolation and Applications of Flat Chitinous 3D Scaffolds from Ianthella labyrinthus (Demospongiae: Verongiida) vol.20, pp.20, 2015, https://doi.org/10.3390/ijms20205105
  6. The virtuous potential of chitosan oligosaccharide for promising biomedical applications vol.35, pp.9, 2015, https://doi.org/10.1557/jmr.2020.76
  7. Development of a Nonwoven Hemostatic Dressing Based on Unbleached Cotton: A De Novo Design Approach vol.12, pp.7, 2015, https://doi.org/10.3390/pharmaceutics12070609
  8. Effect of Celox® Powder on Initial Hemostasis After Cardiac Catheterization in Pediatric Patients with Congenital Heart Disease: A Prospective Study vol.30, pp.4, 2020, https://doi.org/10.5812/ijp.95784
  9. A glimpse on the function of chitosan as a dental hemostatic agent vol.56, pp.1, 2020, https://doi.org/10.1016/j.jdsr.2020.09.001
  10. A promising technology for wound healing; in-vitro and in-vivo evaluation of chitosan nano-biocomposite films containing gentamicin vol.38, pp.2, 2015, https://doi.org/10.1080/02652048.2020.1851789
  11. Comparative Analysis of Collagen and Chitosan-based Dressing for Haemostatic and Wound Healing Application vol.22, pp.3, 2015, https://doi.org/10.1208/s12249-021-01944-9
  12. Hemocompatibility and Hemolytic Effects of Functionalized Nanoparticles on Red Blood Cells: A Recent Review Study vol.16, pp.8, 2015, https://doi.org/10.1142/s1793292021300073
  13. Current trends in chitosan based nanopharmaceuticals for topical vaginal therapies vol.193, pp.no.pb, 2015, https://doi.org/10.1016/j.ijbiomac.2021.11.045
  14. Pharmacological comparison of four biopolymeric natural gums as hemostatic agents for management of bleeding wounds: preliminary in vitro and in vivo results vol.7, pp.1, 2015, https://doi.org/10.1186/s43094-021-00237-z